The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

Ketamine and the use of other psychedelics for mental health disorders has become a more mainstream topic over the past few ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Ketamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.